ANSTO provides groundwork for promising new nuclear medicine
Building on comprehensive work of a former ANSTO researcher Prof Suzanne Smith, Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, has progressed its lead product SARTATE™ from the lab into the clinic for treatment of a range of cancers including neuroendocrine tumours and childhood cancers. The product, a promising molecular imaging…